Division of Samyang Holdings Corp.
Latest From Samyang Biopharmaceuticals
Indonesia’s Kalbe Farma PT has swung into high gear on manufacturing and distribution as the country prepares for the phased launch of universal health care insurance next year and growing incomes in the world’s fourth most populous nation fuel demand.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
- Controlled Release
- Drug Delivery
- Therapeutic Areas
- South Korea
- Pacific Rim
- Parent & Subsidiaries
- Samyang Holdings Corp.
- Senior Management
- Cheolho Gwak, CEO
- Contact Info
Phone: 2 740 7116
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.